On November 7, 2018 Sierra Oncology, Inc. (Nasdaq: SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and oncology, reported that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company entitled "Targeted Therapeutics for Hematology & Oncology" at the Jefferies 2018 London Healthcare Conference in London, United Kingdom (Press release, Sierra Oncology, NOV 7, 2018, View Source [SID1234530842]). The presentation is scheduled for 5:20 p.m. Greenwich Mean Time (GMT) on Wednesday, November 14. A live audio webcast and archive of the presentation will be accessible through www.sierraoncology.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!